PICTET ASSET MANAGEMENT SA - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 323 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT SA ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$42,597,932
+21.5%
1,044,579
+11.1%
0.05%
+15.9%
Q1 2023$35,052,286
+128376.7%
940,496
+20.3%
0.04%
+12.8%
Q4 2022$27,283
-99.9%
781,978
+2.1%
0.04%
-39.1%
Q3 2022$42,874,000
+30.3%
766,162
+20.5%
0.06%
+39.1%
Q2 2022$32,912,000
+23.6%
635,850
+73.5%
0.05%
+53.3%
Q1 2022$26,636,000
-46.6%
366,533
-13.1%
0.03%
-40.0%
Q4 2021$49,893,000
+45.7%
421,964
+65.3%
0.05%
+31.6%
Q3 2021$34,238,000255,2240.04%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders